Independence Bank of Kentucky’s Regeneron Pharmaceuticals REGN Stock Holding History

Independence Bank of Kentucky’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	332 +22	+7%	+$15K	0.02%	280
2026 Q1	$240K	Sell	310 -5	-2%	-$3.83K	0.03%	259
2025 Q4	$243K	Buy	315 +7	+2%	+$4.75K	0.03%	261
2025 Q3	$173K	Buy	308 +22	+8%	+$12.4K	0.02%	297
2025 Q2	$150K	Buy	286 +55	+24%	+$30.7K	0.02%	313
2025 Q1	$147K	Buy	231 +15	+7%	+$10.3K	0.02%	309
2024 Q4	$154K	Buy	216 +30	+16%	+$25.2K	0.02%	303
2024 Q3	$196K	Hold	186	–	–	0.04%	256
2024 Q2	$195K	Hold	186	–	–	0.05%	232
2024 Q1	$179K	Hold	186	–	–	0.05%	229
2023 Q4	$163K	Hold	186	–	–	0.06%	214
2023 Q3	$153K	Hold	186	–	–	0.06%	190
2023 Q2	$134K	Buy	186 +4	+2%	+$3.08K	0.05%	206
2023 Q1	$150K	Hold	182	–	–	0.07%	186
2022 Q4	$131K	Hold	182	–	–	0.06%	193
2022 Q3	$125K	Buy	182 +20	+12%	+$12.6K	0.06%	180
2022 Q2	$96K	Hold	162	–	–	0.04%	206
2022 Q1	$113K	Buy	+162	New	+$102K	0.04%	206
2020 Q1	–	Sell	-12	Closed	-$5K	–	350
2019 Q4	$5K	Hold	12	–	–	﹤0.01%	325
2019 Q3	$3K	Buy	+12	New	+$3.55K	﹤0.01%	329

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Independence Bank of Kentucky's REGN Position: Q2 2026 in Review

Independence Bank of Kentucky increased its Regeneron Pharmaceuticals (REGN) stake by 7.1% in Q2 2026, buying an estimated $15K and bringing the position to 332 shares worth $207K. The position accounts for 0.02% of the portfolio, ranked #280.

Independence Bank of Kentucky first reported a position in REGN in Q3 2019 and has held it in 20 quarters since. The position peaked at $243K in Q4 2025. 569 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Independence Bank of Kentucky held 332 shares of Regeneron Pharmaceuticals worth $207K as of Q2 2026.
Independence Bank of Kentucky bought 22 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $15K.
Regeneron Pharmaceuticals made up 0.02% of Independence Bank of Kentucky's portfolio in Q2 2026, its #280 holding.
Independence Bank of Kentucky first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 20 quarters since.
Independence Bank of Kentucky's Regeneron Pharmaceuticals position peaked at $243K in Q4 2025.
569 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.